Company Filing History:
Years Active: 2014
Title: Harshal Khanwalkar: Innovator in Cancer Treatment
Introduction: Harshal Khanwalkar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. His innovative approach combines established antineoplastic agents with cyclin-dependent kinase inhibitors to enhance therapeutic efficacy.
Latest Patents: Harshal holds a patent for a synergistic pharmaceutical combination for the treatment of cancer. This novel combination includes a cytotoxic antineoplastic agent selected from paclitaxel, docetaxel, doxorubicin, and gemcitabine, or a pharmaceutically acceptable salt thereof. The invention demonstrates synergistic effects when used in cancer treatment, providing a promising method for improving patient outcomes.
Career Highlights: Harshal Khanwalkar is currently employed at Piramal Enterprises Limited, where he continues to develop innovative solutions in the pharmaceutical sector. His work focuses on creating effective treatments that can significantly impact cancer therapy.
Collaborations: Harshal collaborates with talented professionals in his field, including Maggie Rathos and Kalpana Sanjay Joshi. These partnerships enhance the research and development process, fostering an environment of innovation.
Conclusion: Harshal Khanwalkar's contributions to cancer treatment through his patented pharmaceutical combination highlight his role as a leading inventor in the industry. His work exemplifies the potential of innovative approaches to improve healthcare outcomes.